Qian Z - Search Results

1

Pharmacokinetic comparison of sitagliptin and metformin HCl extended-release tablets versus JANUMET^® XR in healthy volunteers under fasting and fed conditions.

Que L, Qin W, Shi Y, Ding Y, Huang K, Qian Z, Huang B, Zhou P, He Q. Que L, et al. Among authors: qian z. Front Pharmacol. 2023 Mar 22;14:1105767. doi: 10.3389/fphar.2023.1105767. eCollection 2023. Front Pharmacol. 2023. PMID: 37033652 Free PMC article.

2

Acarbose bioequivalence: Exploration of eligible protocol design.

Que L, Huang K, Ding Y, Chu N, Yang J, Qian Z, He Q. Que L, et al. Among authors: qian z. J Clin Pharm Ther. 2021 Apr;46(2):492-503. doi: 10.1111/jcpt.13313. Epub 2020 Dec 16. J Clin Pharm Ther. 2021. PMID: 33325562 Clinical Trial.

3

Identification of human uridine diphosphate-glucuronosyltransferase isoforms responsible for the glucuronidation of 10,11-dihydro-10-hydroxy-carbazepine.

Huang K, Que L, Ding Y, Chu N, Qian Z, Qin W, Chen Y, Zhang J, He Q. Huang K, et al. Among authors: qian z. J Pharm Pharmacol. 2021 Mar 6;73(3):388-397. doi: 10.1093/jpp/rgaa059. J Pharm Pharmacol. 2021. PMID: 33793880

4

A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects.

Huang K, Que L, Ding Y, Chu N, Qian Z, Shi Y, Qin W, Li Z, Chen Y, Gu X, Wang J, Zhang L, Zhang J, Zhu X, Yang Y, Tang Y, He Q. Huang K, et al. Among authors: qian z. Front Pharmacol. 2021 Jun 17;12:694375. doi: 10.3389/fphar.2021.694375. eCollection 2021. Front Pharmacol. 2021. PMID: 34220519 Free PMC article.

5

Comparative Pharmacokinetics, Safety, and Immunogenicity Study of the Prefilled Syringe and Lyophilized Formulation of a Recombinant Human Tumor Necrosis Factor-α Receptor II:lgG Fc Fusion Protein in Healthy Chinese Male Subjects.

Huang K, Chu N, Ding Y, Que L, Qian Z, Shi Y, Qin W, He Q. Huang K, et al. Among authors: qian z. Clin Pharmacol Drug Dev. 2022 Sep;11(9):1116-1123. doi: 10.1002/cpdd.1091. Epub 2022 Apr 13. Clin Pharmacol Drug Dev. 2022. PMID: 35419986 Clinical Trial.

6

Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase Ⅰ study.

Huang K, Ding Y, Que L, Chu N, Shi Y, Qian Z, Qin W, Chen Y, Gu X, Wang J, Zhang Z, Xu J, He Q. Huang K, et al. Among authors: qian z. Front Pharmacol. 2022 Nov 4;13:1057949. doi: 10.3389/fphar.2022.1057949. eCollection 2022. Front Pharmacol. 2022. PMID: 36408263 Free PMC article.

7

The effect of food on the pharmacokinetics of WXFL10203614, a potential selective JAK1 inhibitor, in healthy Chinese subjects.

Huang K, Shi Y, Chu N, Que L, Ding Y, Qian Z, Qin W, Gu X, Wang J, Zhang Z, Xu J, He Q. Huang K, et al. Among authors: qian z. Front Pharmacol. 2022 Nov 24;13:1066895. doi: 10.3389/fphar.2022.1066895. eCollection 2022. Front Pharmacol. 2022. PMID: 36506530 Free PMC article.

8

Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions.

Ding Y, Chu N, Que L, Huang K, Chen Y, Qin W, Qian Z, Shi Y, Xu Z, He Q. Ding Y, et al. Among authors: qian z. Front Pharmacol. 2023 Apr 28;14:1169103. doi: 10.3389/fphar.2023.1169103. eCollection 2023. Front Pharmacol. 2023. PMID: 37188262 Free PMC article.

9

Corrigendum: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions.

Ding Y, Chu N, Que L, Huang K, Chen Y, Qin W, Qian Z, Shi Y, Xu Z, He Q. Ding Y, et al. Among authors: qian z. Front Pharmacol. 2023 Jun 1;14:1217008. doi: 10.3389/fphar.2023.1217008. eCollection 2023. Front Pharmacol. 2023. PMID: 37324482 Free PMC article.

10

Evaluation of Acarbose Bioequivalence in Healthy Chinese Populations Using Novel Pharmacodynamic End Points.

Que L, Qian Z, Xiang X, Ding Y, Huang K, Bai Y, Zhao H, He Q. Que L, et al. Among authors: qian z. Clin Pharmacol Drug Dev. 2024 Mar;13(3):233-239. doi: 10.1002/cpdd.1362. Epub 2024 Jan 10. Clin Pharmacol Drug Dev. 2024. PMID: 38197734 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,387 results

Search Page